Holen Sie sich die Stockscreener-App
274.84
1.51%
4.09
Vorhandelsmarkt:
274.80
-0.04
-0.01%
Schlusskurs vom Vortag:
$270.75
Offen:
$270.91
24-Stunden-Volumen:
1.38M
Relative Volume:
0.72
Marktkapitalisierung:
$44.50B
Einnahmen:
$3.32B
Nettoeinkommen (Verlust:
$941.65M
KGV:
48.94
EPS:
5.6161
Netto-Cashflow:
$1.64B
1W Leistung:
+4.20%
1M Leistung:
+10.62%
6M Leistung:
+53.45%
1J Leistung:
-1.12%
1-Tages-Spanne:
$270.68
$276.24
1-Wochen-Bereich:
$257.87
$276.24
52-Wochen-Spanne:
$148.05
$310.50
Veeva Systems Inc Stock (VEEV) Company Profile
Firmenname
Veeva Systems Inc
Sektor
Branche
Telefon
925-452-6500
Adresse
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs TEM, BTSG, TXG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
274.84 | 44.50B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
82.24 | 14.93B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.02 | 11.08B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
84.11 | 10.96B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
91.98 | 7.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2026-02-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2026-01-13 | Fortgesetzt | Goldman | Sell |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-12 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-07 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-09-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-29 | Bestätigt | Needham | Buy |
| 2025-01-23 | Herabstufung | Goldman | Buy → Sell |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-08-27 | Bestätigt | Citigroup | Buy |
| 2024-07-09 | Eingeleitet | BTIG Research | Buy |
| 2023-10-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Truist | Buy → Hold |
| 2023-02-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Eingeleitet | Cowen | Market Perform |
| 2022-12-02 | Bestätigt | Needham | Buy |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | Goldman | Buy |
| 2022-06-21 | Fortgesetzt | Guggenheim | Buy |
| 2022-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2022-01-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Fortgesetzt | Stifel | Buy |
| 2021-09-02 | Bestätigt | BofA Securities | Buy |
| 2021-09-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-09-02 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Eingeleitet | Cowen | Outperform |
| 2021-03-31 | Hochstufung | UBS | Sell → Neutral |
| 2021-01-07 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Fortgesetzt | UBS | Sell |
| 2020-08-28 | Bestätigt | Needham | Buy |
| 2020-07-23 | Eingeleitet | FBN Securities | Outperform |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-06-08 | Eingeleitet | Citigroup | Buy |
| 2020-05-29 | Bestätigt | Needham | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-14 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Bestätigt | Canaccord Genuity | Hold |
| 2019-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Bestätigt | Needham | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Neutral |
| 2019-05-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-27 | Bestätigt | Needham | Buy |
Alle ansehen
Veeva Systems Inc Aktie (VEEV) Neueste Nachrichten
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients - finance.yahoo.com
Veeva Systems Inc. (VEEV) stock price, news, quote and history - Yahoo Finance Australia
EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks - Benzinga
Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch - finance.yahoo.com
Veeva SystemsVault CRM Extends Market Leadership as another Top 20 Biopharma Chooses Veeva - marketscreener.com
Veeva Launches Study Builder Agent to Accelerate Clinical Research - intellectia.ai
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day - Yahoo Finance Singapore
Can Veeva Systems (NYSE:VEEV) Hold Today’s Attention? - Kalkine Media
How Veeva Systems Inc. Class A (VEEV) Affects Rotational Strategy Timing - Stock Traders Daily
Is It Too Late to Buy Veeva Systems Inc (VEEV) After 3.8% Rally? GF Value Says Undervalued - GuruFocus
VEEV Stock Climbs As AI Vault CRM Momentum Fuels Target Hikes - StocksToTrade
Veeva Systems (NYSE:VEEV) Trading Up 2.8%What's Next? - MarketBeat
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing - Zacks Investment Research
Veeva Systems gains on new top 20 biopharma win (VEEV:NYSE) - Seeking Alpha
Vault CRM Extends Market Leadership as Another Top 20 Biopharma Chooses Veeva - Veeva
Veeva Systems adds top 20 biopharma client for Vault CRM By Investing.com - Investing.com Canada
Veeva Systems adds top 20 biopharma client for Vault CRM - Investing.com India
Oxford Biomedica Advances Global Quality Transformation with Veeva Quality Cloud - TradingView
Veeva Systems Inc. $VEEV Shares Sold by Andra AP fonden - MarketBeat
What Is Veeva Systems (VEEV) Telling Investors With Its New Falcon Router? - simplywall.st
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today - finance.yahoo.com
Veeva Systems stock gains as AI tools expand its growth case - ad-hoc-news.de
Veeva Systems (NYSE: VEEV) EVP details stock and option stake - Stock Titan
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan - Your Wyoming Link
Veeva Launches Falcon Router to Enhance Safety Event Handling - intellectia.ai
Veeva Systems launches AI routing tool for drug safety reports By Investing.com - Investing.com Canada
A new tool is planned to send drug-safety reports to the right teams without manual sorting. - Stock Titan
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels - PR Newswire
Veeva Systems Inc. (VEEV) Stock Analysis: Assessing Growth Potential with a 14.25% Upside - DirectorsTalk Interviews
Nykredit A S Takes Position in Veeva Systems Inc. $VEEV - MarketBeat
Integrated Wealth Concepts LLC Sells 4,720 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems stock holds firm as investors digest recent insider sales - AD HOC NEWS
CFRA upgrades Veeva Systems (VEEV) to a Buy - The Globe and Mail
Veeva Systems Inc. (VEEV) Stock forecasts - Yahoo Finance UK
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - finance.yahoo.com
Veeva Systems (VEEV) Insider Sale: Pres. & Chief Customer Officer Thomas Schwenger Sells 1,000 Shares - GuruFocus
Veeva Systems | 4: Statement of changes in beneficial ownership of securities-Officer Schwenger Thomas D. - Moomoo
Veeva Systems Insider Sold Shares Worth $265,200, According to a Recent SEC Filing - marketscreener.com
Veeva Systems (NYSE: VEEV) exec sells 1,000 shares under preset trading plan - Stock Titan
What Veeva Systems (VEEV)'s Amgen CRM Rollout Means For Shareholders - simplywall.st
How to Use AI and Medical Insights to Drive Strategic Impact | Veeva - veeva.com
The Trade Desk, Inc. Expands Integrations with Veeva Systems Inc. and Iqvia Holdings Inc. for Healthcare Measurement and Optimization for Pharma Advertisers - marketscreener.com
Leading Biotech Selects Veeva Vault CRM Globally - Veeva
After $12.8M in sales, Veeva (NYSE: VEEV) executive files notice for another stock sale - Stock Titan
Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target - Yahoo Finance
Director Priscilla Hung Sells 750 Shares of Veeva Systems Inc (V - GuruFocus
Veeva Systems (NYSE: VEEV) director sells 750 shares, now holds 3,242 - Stock Titan
Veeva at Citi’s 2026 Global TMT Conference: ai push deepens By Investing.com - Investing.com Canada
Wells Fargo Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $330 - Moomoo
Veeva Systems (NYSE: VEEV) director lines up 2026 stock sale - Stock Titan
Veeva at Wells Fargo healthcare conference: ai and crm drive growth - Investing.com India
Finanzdaten der Veeva Systems Inc-Aktie (VEEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.38%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):